Last10K.com

Accelera Innovations, Inc. (ACNV) SEC Filing 10-Q Quarterly report for the period ending Saturday, September 30, 2017

Accelera Innovations, Inc.

CIK: 1444144 Ticker: ACNV
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2017
Oct. 25, 2017
Document And Entity Information  
Entity Registrant NameACCELERA INNOVATIONS, INC. 
Entity Central Index Key0001444144 
Document Type10-Q 
Document Period End DateSep. 30, 2017 
Amendment Flagfalse 
Current Fiscal Year End Date--12-31 
Entity Filer CategorySmaller Reporting Company 
Entity Common Stock, Shares Outstanding 81,407,673
Trading SymbolACNV 
Document Fiscal Period FocusQ3 
Document Fiscal Year Focus2017 

View differences made from one quarter to another to evaluate Accelera Innovations, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Accelera Innovations, Inc..

Continue

Assess how Accelera Innovations, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Accelera Innovations, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Condensed Consolidated Balance Sheets (unaudited)
Condensed Consolidated Balance Sheets (unaudited) (parenthetical)
Condensed Consolidated Statements Of Cash Flows (unaudited)
Condensed Consolidated Statements Of Operations (unaudited)
Balance Sheet Information
Balance Sheet Information (details Narrative)
Balance Sheet Information (tables)
Balance Sheet Information - Schedule Of Property And Equipment (details)
Commitments And Contingencies
Commitments And Contingencies (details Narrative)
Convertible Notes
Convertible Notes (details Narrative)
Convertible Notes (tables)
Convertible Notes - Schedule Of Convertible Notes (details)
Convertible Notes - Schedule Of Convertible Notes (details) (parenthetical)
Convertible Notes - Schedule Of Rollforward Convertible Notes (details)
Derivative Liability
Derivative Liability (tables)
Derivative Liability - Schedule Of Assumptions To Measure The Fair Value Of Derivative Liability (details)
Derivative Liability - Schedule Of Derivative Liability Activity (details)
Going Concern
Going Concern (details Narrative)
Organization And Basis Of Presentation
Organization And Basis Of Presentation (details Narrative)
Related Party Transactions
Related Party Transactions (details Narrative)
Restatement Of Previously Issued Financial Statements
Restatement Of Previously Issued Financial Statements (details Narrative)
Restatement Of Previously Issued Financial Statements (tables)
Restatement Of Previously Issued Financial Statements - Summary Of Restated Financial Statements (details)
Short-term Notes Payables
Short-term Notes Payables (details Narrative)
Short-term Notes Payables (tables)
Short-term Notes Payables - Schedule Of Short-term Notes Payable (details)
Short-term Notes Payables - Schedule Of Short-term Notes Payable (details) (parenthetical)
Stock-based Compensation
Stock-based Compensation (details Narrative)
Stock-based Compensation (tables)
Stock-based Compensation - Schedule Of Outstanding Options (details)
Stockholders' Deficit
Stockholders' Deficit (details Narrative)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (details Narrative)
Summary Of Significant Accounting Policies (policies)
Summary Of Significant Accounting Policies (tables)
Summary Of Significant Accounting Policies - Schedule Of Fair Value Of Derivative Liability (details)

Material Contracts, Statements, Certifications & more

Accelera Innovations, Inc. provided additional information to their SEC Filing as exhibits

Ticker: ACNV
CIK: 1444144
Form Type: 10-Q Quarterly Report
Accession Number: 0001493152-17-012243
Submitted to the SEC: Wed Nov 01 2017 6:06:15 AM EST
Accepted by the SEC: Wed Nov 01 2017
Period: Saturday, September 30, 2017
Industry: Health Services

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/acnv/0001493152-17-012243.htm